Sumitomo Dainippon Pharma

Nov. 12, 2018 (PDF/127KB)Related Business

Announcement of the establishment of new joint company by Sumitomo Bakelite Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd.
Nov. 05, 2018Finances

Posted Video of Investors Meeting Presentation for Q2 FY2018 [Webcast]
Nov. 02, 2018 (PDF/116KB)R&D

Sumitomo Dainippon Pharma announces the Clinical Data of Investigational Anti-Cancer Agent Alvocidib will be presented at ASH 2018
Oct. 30, 2018 (PDF/739KB)Finances

Investors Meeting Presentation for Q2 FY2018
Oct. 30, 2018 (PDF/484KB)Finances

Supplementary Financial Data (IFRS) for the Second Quarter of the Year Ending March 31, 2019

Other Notices

Sep. 27, 2018CSR (PDF/179KB)

Sumitomo Dainippon Pharma Selected as a Component of Dow Jones Sustainability Indices (DJSI) for the second Consecutive Year
Sep. 27, 2018CSR (PDF/186KB)

Sumitomo Dainippon Pharma Receives the Award of Gold Class in Overall Category of SUSTAINA ESG AWARD 2018
Sep. 19, 2018CSR (PDF/79KB)

Sumitomo Dainippon Pharma Contributes to the 2018 Hokkaido Eastern Iburi Earthquake Relief Efforts in Japan

IR Library